Practice patterns for spasticity management with phenol neurolysis
Jay Karri, Manuel F. Mas, Gerard E. Francisco, Sheng Li
Physical Medicine and Rehabilitation, University of Texas Health Science Center at Houston McGovern Medical School, USA
DOI: 10.2340/16501977-2239
Lay Abstract
Phenol neurolysis is currently used, but not as common as compared to botulinum toxin injections, for spasticity management. In this study, we reviewed 293 phenol neurolysis procedures performed in 185 patients with different impairments (stroke, traumatic brain injury, and spinal cord injury) over last 3 years in our institution. Depending on the pattern of spastcity displayed, numerous peripheral nerves in the upper and lower extremities can be targeted. Majority of patients reported subjective benefits . Post-procedure adverse effect rates were low (<4%).
Supplementary content
